Related Experiment Video
Updated: Dec 30, 2025

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
Published on: February 10, 2022
Ethical considerations for cardiac surgical interventions in children with trisomy 13 and trisomy 18
Kathryn Neubauer1, Renee D Boss1
1Pediatric Palliative Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Insights
Medical and surgical care for children with trisomy 13 and 18 is advancing, drawing parallels with historical changes in trisomy 21 care. However, greater variability in conditions complicates surgical risk-benefit assessments.
Area of Science:
- Pediatric Cardiology
- Medical Genetics
- Bioethics
Background:
- Medical and surgical interventions for trisomy 13 and 18 are evolving.
- Care paradigms for these conditions are shifting, mirroring historical changes observed for trisomy 21.
- Increased consideration for cardiac procedures in affected children is noted.
Purpose of the Study:
- To review the evolving medical and surgical approaches for children with trisomy 13 and 18.
- To compare current care shifts with historical trends in trisomy 21 management.
- To analyze the complexities influencing surgical intervention decisions.
Main Methods:
- Literature review of medical and social considerations.
- Comparative analysis of care trends across different trisomies.
- Discussion of variability in cardiac and non-cardiac comorbidities.
Main Results:
- Significant variability in cardiac lesions and non-cardiac comorbidities exists in trisomy 13 and 18 patients, exceeding that seen in trisomy 21.
- Severe neurologic impairment in survivors presents a major challenge.
- The risk:benefit balance for surgical intervention is complicated by this variability.
Conclusions:
- Care approaches for trisomy 13 and 18 require an evidence base.
- Integration of medical ethics and palliative care specialists is crucial.
- Consistent care strategies must address the unique complexities of these genetic conditions.
Abstract:
Medical and surgical approaches to children with trisomy 13 and 18 are evolving, and an increasing number of patients are being considered for simple and complex cardiac procedures. This review describes how the shifts in medical and social considerations for children with trisomy 13 and 18 mirror the shifts that occurred 50 years ago for children with trisomy 21. Yet the variability in cardiac lesions, and variability in non-cardiac comorbidities, is much greater for patients with trisomy 13 and 18 than for those with trisomy 21. That variability, combined with the severe neurologic impairment in survivors, complicates the current risk: benefit balance of surgical intervention. Consistent approaches to care for these patients should be built on an evidence base, and should include contributions from specialists in medical ethics and palliative care.
Related Concept Videos
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Kidney Transplant I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization III: Left Heart Catheterization
Cardiomyopathy III: Hypertrophic Cardiomyopathy

